The emergence of mRNA vaccines has revolutionized the field of immunization, promising rapid development and high efficacy against various infectious diseases, including COVID-19. Central to the success of these vaccines is the use of lipid nanoparticles (LNPs), particularly ALC-0315, which has been identified as a core component in enhancing mRNA delivery and immune responses. This article...
English
العربية
Français
Español
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt